Using active surveillance for Gleason 7 (3+4) prostate cancer
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , |
Tipo de documento: | Outros |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/162354 |
Resumo: | Funding Information: Acknowledgement: RB is supported by FCT (2022.13386.BD). Publisher Copyright: © 2024 Canadian Urological Association. All rights reserved. |
id |
RCAP_6ab392971a8305309ef39c46043d804b |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/162354 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Using active surveillance for Gleason 7 (3+4) prostate cancerA narrative reviewUrologySDG 3 - Good Health and Well-beingFunding Information: Acknowledgement: RB is supported by FCT (2022.13386.BD). Publisher Copyright: © 2024 Canadian Urological Association. All rights reserved.The interest in broadening the application of active surveillance (AS) has been increasing, encompassing patients who may not strictly adhere to the conventional criteria for low-risk prostate cancer (PCa), particularly those diagnosed with small-volume Gleason grade group 2 disease. Nonetheless, accurately identifying individuals with low-intermediate risk PCa who can safely undergo AS without facing disease progression remains a challenge. This review aims to delve into the progression of this evolving trend specifically within this cohort of men, while also examining strategies aimed at minimizing irreversible disease advancement. Additionally, we address the criteria for patient selection, recommended followup schedules, and the indicators prompting intervention.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNBernardino, RuiSayyid, Rashid K.Leão, RicardoZlotta, Alexandre R.vander Kwast, TheodorusKlotz, LaurenceFleshner, Neil E.2024-01-16T22:36:48Z2024-042024-04-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/otherapplication/pdfhttp://hdl.handle.net/10362/162354eng1911-6470PURE: 81473263https://doi.org/10.5489/cuaj.8539info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-22T18:17:25Zoai:run.unl.pt:10362/162354Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-22T18:17:25Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Using active surveillance for Gleason 7 (3+4) prostate cancer A narrative review |
title |
Using active surveillance for Gleason 7 (3+4) prostate cancer |
spellingShingle |
Using active surveillance for Gleason 7 (3+4) prostate cancer Bernardino, Rui Urology SDG 3 - Good Health and Well-being |
title_short |
Using active surveillance for Gleason 7 (3+4) prostate cancer |
title_full |
Using active surveillance for Gleason 7 (3+4) prostate cancer |
title_fullStr |
Using active surveillance for Gleason 7 (3+4) prostate cancer |
title_full_unstemmed |
Using active surveillance for Gleason 7 (3+4) prostate cancer |
title_sort |
Using active surveillance for Gleason 7 (3+4) prostate cancer |
author |
Bernardino, Rui |
author_facet |
Bernardino, Rui Sayyid, Rashid K. Leão, Ricardo Zlotta, Alexandre R. vander Kwast, Theodorus Klotz, Laurence Fleshner, Neil E. |
author_role |
author |
author2 |
Sayyid, Rashid K. Leão, Ricardo Zlotta, Alexandre R. vander Kwast, Theodorus Klotz, Laurence Fleshner, Neil E. |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
dc.contributor.author.fl_str_mv |
Bernardino, Rui Sayyid, Rashid K. Leão, Ricardo Zlotta, Alexandre R. vander Kwast, Theodorus Klotz, Laurence Fleshner, Neil E. |
dc.subject.por.fl_str_mv |
Urology SDG 3 - Good Health and Well-being |
topic |
Urology SDG 3 - Good Health and Well-being |
description |
Funding Information: Acknowledgement: RB is supported by FCT (2022.13386.BD). Publisher Copyright: © 2024 Canadian Urological Association. All rights reserved. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-01-16T22:36:48Z 2024-04 2024-04-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/other |
format |
other |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/162354 |
url |
http://hdl.handle.net/10362/162354 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1911-6470 PURE: 81473263 https://doi.org/10.5489/cuaj.8539 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817545979900985344 |